Systemic Rituximab Immunotherapy in the Management of Primary Ocular Adnexal Lymphoma: Single Institution Experience

Tuncer S., Tanyildiz B., Basaran M., Buyukbabani N., Dogan O.

CURRENT EYE RESEARCH, vol.40, no.8, pp.780-785, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 40 Issue: 8
  • Publication Date: 2015
  • Doi Number: 10.3109/02713683.2014.959605
  • Journal Name: CURRENT EYE RESEARCH
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.780-785
  • Istanbul University Affiliated: Yes

Abstract

Purpose: To evaluate the efficacy of systemic rituximab immunotherapy in the management of primary ocular adnexal lymphomas (OAL).